Topical anesthetics reduce procedural pain by reversibly blocking voltage-gated sodium channels in superficial sensory nerves. This prevents sufficient sodium influx to depolarize the nerve membrane, so pain signals cannot generate or propagate to the central nervous system. Their penetration is primarily limited by the stratum corneum, especially its tightly organized intercellular lipid matrix.
Topical anesthesia works by raising the excitation threshold of cutaneous nociceptors, while the stratum corneum acts as the main barrier restricting anesthetic delivery into the viable epidermis and dermis.
How Topical Anesthetics Interrupt Pain Signaling
The target is the peripheral nociceptor
Energy-based procedures can stimulate free dermal nerve endings, or nociceptors, through heat, mechanical disruption, or tissue injury. These sensory endings convert the stimulus into an electrical signal that can be transmitted toward the spinal cord and brain.
Topical anesthetics act locally on these superficial sensory fibers rather than producing a generalized loss of sensation throughout the body.
Sodium-channel blockade prevents depolarization
Nerve impulses depend on the opening of voltage-gated sodium channels. Sodium ions normally enter the nerve membrane, causing rapid depolarization and initiating an action potential.
Local anesthetics such as lidocaine and prilocaine reversibly bind within these channels and reduce sodium influx. If the membrane cannot depolarize sufficiently, the action potential is not generated or cannot propagate along the sensory nerve fiber.
The excitation threshold becomes higher
The practical result is an increased threshold for nerve excitation. A laser pulse, radiofrequency treatment, or microneedling stimulus must therefore be stronger to activate the treated nerve—and may fail to produce a pain signal altogether.
This effect is temporary and localized, because the anesthetic gradually diffuses away and is eventually cleared from the tissue.
Why the Stratum Corneum Limits Penetration
It is the principal cutaneous barrier
The stratum corneum is the outermost layer of the epidermis and the primary rate-limiting barrier to topical drug absorption. It consists of compact, keratinized cells surrounded by an intercellular lipid matrix.
That matrix contains lipids such as ceramides, fatty acids, and cholesterol, which restrict the movement of many molecules toward the deeper viable epidermis and dermis.
Anesthetic must reach the nerve endings
The anesthetic must cross the stratum corneum and diffuse into the superficial tissue where cutaneous nociceptors are located. The thicker or less permeable the barrier, the slower and less complete this delivery becomes.
This is why topical anesthesia generally provides better superficial analgesia than anesthesia of deeper structures.
Formulation affects delivery
Formulations can improve passage through the barrier. Eutectic mixtures, such as lidocaine–prilocaine preparations, improve the ability of the active ingredients to partition into the skin, while other delivery systems—such as liposomal formulations—can modify release and absorption.
These approaches improve penetration but do not eliminate the stratum corneum as the fundamental limiting barrier.
What Determines the Depth of Anesthesia
Application time matters
In general, longer contact allows more anesthetic to diffuse through the stratum corneum and into the superficial dermis. Eutectic topical anesthetics may produce increasing dermal anesthesia with longer application, with reported depths varying by formulation, occlusion, skin site, and treatment conditions.
Depth should therefore not be assumed from the product name alone; it depends on the specific preparation and protocol.
Treatment depth must match anesthetic depth
Fractional lasers, microneedle radiofrequency devices, and other energy-based technologies can affect tissue at different depths. A topical anesthetic may reduce pain from superficial nerve endings without fully anesthetizing deeper structures.
For deeper or more painful procedures, clinicians may need additional strategies, such as local infiltration, nerve blocks, cooling, or carefully controlled device parameters.
Understanding the Trade-offs
More exposure can increase systemic absorption
Increasing the dose, application time, treated surface area, or degree of skin penetration can improve analgesia. It can also increase systemic absorption and the risk of adverse effects.
The lowest effective amount should be used, particularly when treating large areas or compromised skin.
Protocol limits are product-specific
Commonly cited limits—such as restricting application to approximately one hour or limiting the treated area—should not be treated as universal rules. Maximum dose, application time, area, occlusion, and use on intact versus disrupted skin must follow the specific product labeling and clinical protocol.
Barrier disruption changes risk
Energy devices and microneedling can weaken or breach the stratum corneum. Applying anesthetic before treatment allows absorption through intact skin, whereas applying it to freshly disrupted skin can substantially increase penetration and systemic exposure.
This distinction is clinically important and should be incorporated into the treatment plan.
How to Apply This to Your Project
The key is to match the anesthetic formulation and exposure protocol to the expected treatment depth while respecting absorption limits.
- If your primary focus is patient comfort: Use an appropriately formulated topical anesthetic with sufficient contact time before energy delivery, recognizing that it primarily affects superficial cutaneous nociceptors.
- If your primary focus is safety: Follow the specific product’s dose, area, duration, and skin-condition restrictions, and avoid assuming that deeper penetration always provides a better risk–benefit balance.
- If your primary focus is treatment of deeper tissue: Do not rely on topical anesthesia alone; consider whether additional local anesthetic or nonpharmacologic pain-control methods are required.
- If your primary focus is formulation performance: Evaluate how the vehicle, occlusion, skin integrity, and application time affect passage through the stratum corneum.
Understanding both the sodium-channel mechanism and the stratum-corneum barrier allows topical anesthesia to be used more predictably and safely during energy-based aesthetic treatments.
Summary Table:
| Aspect | Mechanism | Limitation |
|---|---|---|
| Pain signaling | Topical anesthetics block voltage-gated sodium channels, preventing nerve depolarization and pain signal propagation. | Anesthetic must reach nerve endings in the dermis, which is hindered by the stratum corneum. |
| Barrier | Stratum corneum's lipid matrix restricts drug penetration. | Thickness and composition vary by site, affecting anesthetic depth. |
| Formulation | Eutectic mixtures and liposomes enhance skin penetration. | Cannot completely overcome the barrier; depth is limited. |
| Application | Longer contact times increase diffusion depth. | Overexposure increases systemic absorption risk. |
| Depth match | Choose anesthetic based on treatment depth. | Deeper procedures may require additional pain control methods. |
Enhance patient comfort and safety in your aesthetic practice. At BELIS, we specialize in advanced laser and energy-based devices designed for clinics and premium salons. Our portfolio includes diode laser, IPL, CO2 fractional, and more—engineered to maximize treatment efficacy while minimizing discomfort. Contact us today to learn how our technology can elevate your practice and patient satisfaction. Contact us now.